Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

Men with high-grade prostate cancer and low prostate-specific antigen (PSA) levels have a poor prognosis. The question remains as to whether the chemotherapy drug docetaxel, which increases survival ...

Thousands of men with early-stage prostate cancer in England will soon have access to a new form of radiotherapy on the NHS ...

(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...

A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific antigen (PSA) screening. However, the findings also highlight the issue of ...

The use of prostate-specific antigen (PSA) testing for prostate cancer screening remains the subject of scientific debate. Experts are unable to agree on how to balance the benefit of such testing ...

A dose reduction of Erleada may result in fewer skin-related side effects for men with advanced prostate cancer — but only for those with a smaller body size, research showed. A dose reduction of ...

NHS advisors have again rejected pleas for potentially life-saving routine prostate cancer screening after concluding that ...

Three-dimensional ultrasound-based spectroscopic imaging for the detection of prostate cancer. Background: We previously reported that physical activity may reduce prostate cancer (CaP) risk among men ...